THE US Food and Drug Administration has approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes and cardiovascular disease.
PEOPLE with obesity who take glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reduced risk of cancer compared to those not using those medications, according to US research published today in JAMA Oncology.
PHARMACISTS from across Australia recently came together for the Pharmacy Snow Business Conference at Mt Buller, sharing a passion for skiing alongside their commitment to professional development.
PHARMX Technologies yesterday announced strong results for the financial year ending 30 Jun 2025, with total revenues of $7.5 million, up 13% on the previous corresponding period.
Notifications
